Strategy of the pharmaceutical industry development in terms of external constraints

#9. Execution Excess
Strategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraintsStrategy of the pharmaceutical industry development in terms of external constraints

Considering the trends of the Russian pharmaceutical industry development, we should bear in mind the existing external constraints, in the first place it is necessary to highlight the need to comply with the WTO rules and regulations, as well as the growing political and military pressure, intensifying economic sanctions against Russia from the part of the world leading countries. In this context, the article discusses the current state of the Russian pharmaceutical industry, strategic options of its development and the concomitant risks.